Europeanhhm

QIAGEN and Myriad Genetics Join Forces to Advance the Development of Companion Diagnostics for Cancer

Friday, October 27, 2023

QIAGEN and Myriad Genetics have recently announced a significant collaborative agreement with a focus on advancing the development of companion diagnostic tests in the field of cancer. This partnership aims to provide innovative solutions and products for pharmaceutical companies, supporting the creation and commercialization of exclusive cancer tests for the U.S. clinical market, as well as the distribution of companion diagnostic test kits on a global scale.

The collaboration between QIAGEN and Myriad Genetics brings together the distinct strengths of each company. Myriad Genetics possesses a CLIA-certified, CAP-accredited laboratory platform, expertise in assay development, and a robust infrastructure for clinical sample testing. Meanwhile, QIAGEN offers Sample to Insight solutions, encompassing sample preparation, PCR, digital PCR (using the QIAcuity system), QIAseq next-generation sequencing (NGS) technologies, state-of-the-art instruments, and the QIAGEN Digital Insights bioinformatics portfolio. Additionally, QIAGEN provides GMP-certified product manufacturing capabilities and a well-established global commercial network.

This partnership also benefits from the combined expertise of both companies in dealing with FDA and international regulatory requirements, ensuring seamless compliance and integration in clinical and companion diagnostic applications.

Initially, the joint efforts of QIAGEN and Myriad Genetics will involve collaboration with pharmaceutical partners to develop assays using next-generation sequencing workflows or QIAGEN's digital PCR platform, QIAcuity. Myriad Genetics has a strong track record of providing essential testing support for numerous clinical trials and has achieved approvals for ten companion diagnostics from the FDA and PMDA.

Source: globenewswire.com

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024